LIQ861

treprostinil · Liquidia Technologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LIQ861, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil [Phase 3]

See pricing